Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Potential Role of Allopurinol Versus Atorvastatin to Prevent Complications of Liver Cirrhosis: A Quadruple Blind Clinical Study

NCT05511766 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT05511766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05511766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Potential Role of Allopurinol Versus Atorvastatin to Prevent Complications of Liver Cirrhosis: A Quadruple Blind Clinical Study
Lead sponsor
Tanta University
Phase
Phase 2/3
Overall status
Completed
Start date
November 15, 2022
Completion date
January 25, 2026
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ascites, cirrhosis, hepatic encephalopathy, sbp - spontaneous bacterial peritonitis, varices